Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Clinical trial NCT04168333 · COMPLETED

Trial details

NCT number: NCT04168333
Sponsor: Tasly Tianjin Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis B Virus (HBV)

Start date: 2018-01-08
Primary completion: 2019-10-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.